Methotrexate-associated lymphoma in patients with rheumatoid arthritis: Report of two cases

Arthritis and Rheumatism

Volumn 39, Issue 2, 1996, Pages 325-329

  Bachman, Teresa R ^a   Sawitzke, Allen D ^a   Perkins, Sherrie L ^a   Ward, John H ^a   Cannon, Grant W ^a  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; AURANOFIN; AZATHIOPRINE; CD20 ANTIGEN; CD45 ANTIGEN; CD5 ANTIGEN; CEFALEXIN; CEFAZOLIN; CYCLOPHOSPHAMIDE; DNA; FOLIC ACID; GOLD; HYDROXYCHLOROQUINE; IBUPROFEN; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; LEUKOSIALIN; LISINOPRIL; METHOTREXATE; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PENICILLAMINE; PREDNISONE; QUININE SULFATE; SALAZOSULFAPYRIDINE; SALSALATE; SUPEROXIDE DISMUTASE; THYMOPOIETIN;

AGED; ARTICLE; ASPIRATION; B CELL LYMPHOMA; BACTERIAL ARTHRITIS; BIOPSY; CASE REPORT; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; EPSTEIN BARR VIRUS; FEMALE; HAND RADIOGRAPHY; HUMAN; IN SITU HYBRIDIZATION; INTRAVENOUS DRUG ADMINISTRATION; LARGE CELL LYMPHOMA; MALE; ORAL DRUG ADMINISTRATION; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

AGED; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL; MALE; METHOTREXATE;

EID: 0030067418     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780390223     Document Type: Article

References (21)

1. Ellman M, Hurwitz H, Thomas C, Kozloff M: Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate. J Rheumatol 18:1741-1743, 1991
2. Cobeta-Garcia J, Ruiz-Jimeno M, Fontova-Garrofe R: Non-Hodgkin's lymphoma, rheumatoid arthritis and methotrexate. J Rheumatol 20:200-201, 1993
3. Liote F, Pertuiset E, Cochand-Priollet B, D'Agay M-F, Dombret H, Numeric P, D'Anglejan G, Kuntz D: Methotrexate related B lymphoproliferative disease in a patient with rheumatoid arthritis: role of Epstein-Barr virus infection. J Rheumatol 22:1174-1178, 1995
4. Kingsmore S, Hall B, Allen N, Rice J, Caldwell D: Association of methotrexate, rheumatoid arthritis and lymphoma: report of 2 cases and literature review. J Rheumatol 19:1462-1465, 1992
5. Morris C, Morris A: Localized lymphoma in a patient with rheumatoid arthritis treated with parenteral methotrexate. J Rheumatol 20:2172-2173, 1993
6. Taillan B, Gamier G, Ferrari E, Castanet J, Pesce A. Fuzibet J, Dujardin P: Malignant lymphoma in a patient with rheumatoid arthritis treated with low-dose methotrexate. Rev Rhum 60:214-216, 1993
7. Kamel O, Van de Rijn M, Weiss L, Del Zoppo G, Hench P, Robbins B, Montgomery P, Warnke R, Dorfman R: Reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. N Engl J Med 328:1317-1321, 1993
8. Shiroky J, Frost A, Skelton J, Haegert D, Newkirk M, Neville C: Complications of immunosuppression associated with weekly low dose methotrexate. J Rheumatol 18:1172-1175, 1991
9. Weiss L. Movahed L: In situ demonstration of Epstein-Barr genomes in viral-associated B-cell lymphoproliferations. Am J Pathol 134:651-659, 1989
10. Reed T. Reid A, Wallberg K, O'Leary T, Frizera G: Determination of B-cell clonality in paraffin-embedded lymph nodes using the polymerase chain reaction. Diagn Mol Pathol 2:14-24, 1993
11. Wan J, Trainor K, Briscom M, Morey A: Monoclonality in B cell lymphoma detected in paraffin wax embedded sections using the polymerase chain reaction. J Clin Pathol 43:888-890, 1990
12. Prior P: Cancer and rheumatoid arthritis: epidemiologic considerations. Am J Med 78:15-21, 1985
13. Gridley G, Klippel J, Hoover R, Fraumeni J: Incidence of cancer among men with the Felty syndrome. Ann Intern Med 120:35-39, 1994
14. Kamel O, van de Rijn M, LeBrun D, Weiss L, Warnke R, Dorfman R: Lymphoid neoplasms in patients with rheumatoid arthritis and dermatomyositis: frequency of Epstein-Barr virus and other features associated with immunosuppression. Hum Pathol 25:638-643, 1994
15. Tosato G, Steinberg A, Yarchoan R, Heilman C, Pike S, De Seau V, Blaese R: Abnormally elevated frequency of EpsteinBarr virus-infected B cells in the blood of patients with rheumatoid arthritis. J Clin Invest 73:1789-1795, 1984
16. Depper J, Bluestein H, Zvaifler N: Impaired regulation of Epstein-Barr virus-induced lymphocyte proliferation in rheumatoid arthritis is due to a T cell defect. J Immunol 127:1899-1902, 1981
17. Nalesnik M, Makowka L, Starzl T: The diagnosis and treatment of posttransplant lymphoproliferative disorders. Curr Probl Surg 25:365-472, 1988
18. Ho M, Miller G, Atchison R, Breinig M, Dummer J, Andiman W, Starzl T, Eastman R. Griffith B, Hardesty R, Bahnson H, Hakala T, Rosenthal J: Epstein-Barr virus infection and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection. J Infect Dis 152:876-886, 1985
19. Morrison V, Dunn D, Manivel J, Gajl-Peczaiska K, Peterson B: Clinical characteristics of post-transplant lymphoproliferative disorders. Am J Med 97:14-24, 1994
20. Hanto D, Gajl-Peczalska K, Frizzera G, Arthur D, Balfour H, McClain K, Simmons R, Najarian J: Epstein-Barr virus induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Ann Surg 198:356-369, 1983
21. Hanto D, Frizzera G, Gajl-Peczalska KJ, Balfour H, Simmons R, Najarian J: Acyclovir therapy of Epstein-Barr virus-induced posttransplant lymphoproliferative diseases. Transplant Proc 17:89-92, 1985